A-366

N/A

Report date: 2023/03/23 13:28:30

NME

Base Information

Drug NameA-366

Drug Alias NameA-366

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionHistone-lysine N-methyltransferase EHMT2 inhibitors

TargetsHistone-lysine N-methyltransferase EHMT2

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbbvie Inc

China Registration ClassN/A

Active CompaniesAbbvie Inc

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

ATC CodeN/A